Quanterix (NASDAQ:QTRX) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Quanterix (NASDAQ:QTRX) posted its quarterly earnings results on Monday. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Price Performance

Shares of QTRX stock traded up $0.22 on Monday, hitting $7.28. The company’s stock had a trading volume of 564,582 shares, compared to its average volume of 809,174. Quanterix has a fifty-two week low of $6.80 and a fifty-two week high of $27.37. The firm’s fifty day moving average price is $8.59 and its 200-day moving average price is $11.01. The stock has a market capitalization of $280.45 million, a price-to-earnings ratio of -6.87 and a beta of 1.33.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.